Martin Osugo

11PUBLICATIONS
31CO-AUTHORS
Clinical neuropsychologyMedical biotechnology diagnostics (incl. biosensors)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Toxicology (incl. clinical toxicology)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 21, 2026
What is Minimally Adequate Treatment of Psychosis and Should Duration of Inadequate Treatment be a Clinical and Research Target? A Perspective and State-of-the-Art Review.

Martin Osugo, Oliver D Howes

|Mar 21, 2026
Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.

Claudio Agnorelli, Joseph Peill, Gabriela Sawicka

|Feb 02, 2026
Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [<sup>11</sup>C]UCB-J positron emission tomography study.

Ellis Chika Onwordi, Thomas Whitehurst, Ekaterina Shatalina

|Jul 19, 2025
Effects of antipsychotics on human cognitive function: causal evidence from healthy volunteers following sustained D2/D3 antagonism, D2/D3 partial agonism and placebo.

Martin Osugo, Uzma Zahid, Pierluigi Selvaggi

|May 07, 2025
Antipsychotics cause reversible structural brain changes within one week.

Pierluigi Selvaggi, Martin Osugo, Uzma Zahid

|Mar 02, 2025
The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study.

Ellis Chika Onwordi, Thomas Whitehurst, Ekaterina Shatalina

Pageof 2

Frequent Collaborators

6 joint publications

Oliver D Howes

5 joint publications

Tiago Reis Marques

3 joint publications

Eugenii A Rabiner

3 joint publications

Mitul A Mehta